These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2537253)

  • 1. Evaluation of the mouse model for study of encephalopathy in pertussis vaccine recipients.
    Hewlett EL; Cowell JL
    Infect Immun; 1989 Mar; 57(3):661-3. PubMed ID: 2537253
    [No Abstract]   [Full Text] [Related]  

  • 2. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis.
    Vandebriel RJ; Gremmer ER; Vermeulen JP; Hellwig SM; Dormans JA; Roholl PJ; Mooi FR
    Vaccine; 2007 Mar; 25(12):2346-60. PubMed ID: 17224216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine model for pertussis vaccine encephalopathy: role of the major histocompatibility complex; antibody to albumin and to Bordetella pertussis and pertussis toxin.
    Steinman L; Weiss A; Adelman N; Lim M; Oehlert J; Zuniga R; Hewlett E; Falkow S
    Dev Biol Stand; 1985; 61():439-46. PubMed ID: 2872126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
    Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A polyvalent complex of Bordetella pertussis antigens as the basis for an acellular pertussis vaccine].
    Zakharova NS; Shmeleva EI; Remova TN; Bazhanova IG; Ozeretskovskaia MN; Mertsalova NU; Britsina MV; Ermolova EV; Zaĭtsev EM
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (3):70-2. PubMed ID: 9304336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant iron transport protein from Bordetella pertussis confers protection against Bordetella parapertussis.
    Alvarez Hayes J; Oviedo JM; Valdez H; Laborde JM; Maschi F; Ayala M; Shah R; Fernandez Lahore M; Rodriguez ME
    Microbiol Immunol; 2017 Oct; 61(10):407-415. PubMed ID: 28857261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis antigens--screening models on toxicity.
    Ronneberger H; Blackkolb F; Guthöhrlein G
    Arch Toxicol Suppl; 1982; 5():129-32. PubMed ID: 6285854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoprophylaxis in pertussis.
    Deb M
    J Commun Dis; 1984 Mar; 16(1):54-60. PubMed ID: 12055788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
    Debrie AS; Coutte L; Raze D; Mooi F; Alexander F; Gorringe A; Mielcarek N; Locht C
    Vaccine; 2018 Mar; 36(11):1345-1352. PubMed ID: 29433898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The expression of Bordetella pertussis protective antigens during bacterial multiplication on a medium with a fixed chemical composition].
    Shmeleva EI; Mertsalova NU; Sukhinova EV; Kirillova GA; Remova TN; Bazhanova IG; Ozeretskovskaia MN; Britsina MV; Ermolova EV; Zakharova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):47-50. PubMed ID: 9245141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the indices of humoral and cellular immunity induced in mice of various genotypes by pertussis antigens].
    Moskalenko EP; Il'ina SI; Plavan VV
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Nov; (11):89-92. PubMed ID: 6318483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hydromechanical stress on cellular antigens of Bordetella pertussis.
    Rodriguez ME; Hozbor DF; Yantorno OM
    J Ind Microbiol; 1996 Jul; 17(1):53-5. PubMed ID: 8987690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of the biological properties of a cell-free pertussis preparation].
    Zakharova NS; Remova TN; Bazhanova IG; Ozeretskovskaia MN; Shmeleva EI
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jun; (6):38-43. PubMed ID: 2888247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pertussis toxin is required for pertussis vaccine encephalopathy.
    Steinman L; Weiss A; Adelman N; Lim M; Zuniga R; Oehlert J; Hewlett E; Falkow S
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8733-6. PubMed ID: 2867545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccine from cellular fragments of B. pertussis. II. Toxic properties of the vaccine].
    Shirko GN; Zakharova MS
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jul; (7):68-74. PubMed ID: 211762
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bordetella pertussis spheroplasts. 4. The protective, histamine-sensitizing and toxic action of spheroplasts and spheroplast cell walls].
    Milleck J; Ocklitz HW
    Zentralbl Bakteriol Orig A; 1972 Mar; 219(3):358-65. PubMed ID: 4122376
    [No Abstract]   [Full Text] [Related]  

  • 17. [Relationship of the sensitizing and protective properties of pertussis antigens].
    Lebedev VS; Selezneva VP; Moshiashvili IIa; Zakharova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1982 May; (5):83-7. PubMed ID: 6285648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential immunogens in human pertussis: the role of fimbriae.
    Preston NW
    Dev Biol Stand; 1985; 61():137-41. PubMed ID: 2872099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Components of acellular pertussis vaccines.
    Preston NW; Matthews RC
    Lancet; 1996 Mar; 347(9003):764. PubMed ID: 8602023
    [No Abstract]   [Full Text] [Related]  

  • 20. Acellular pertussis trial.
    Hewlett EL
    Pediatrics; 1996 Oct; 98(4 Pt 1):800. PubMed ID: 8885972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.